In a separate experiment we examined the effects of these Abs on the growth of tumor cells expressing EGFR In Vitro and In Vivo, that is, in athymic mice and reported that the results are very heterogeneous among the Abs that included already approved therapeutic Abs, Erbitux and Vectibix [23]. The gene discussed is EGFR; the disease is neoplasm.